Literature DB >> 35349106

A method for evaluating drug penetration and absorption through isolated buccal mucosa with highly accuracy and reproducibility.

Shuangqing Wang1,2, Lei Liu1, Saige Meng1, Yuling Wang3, Daofeng Liu4, Zhonggao Gao5,6, Along Zuo7, Jianpeng Guo8.   

Abstract

The purpose of the project is to establish a standardized operation method of the in vitro permeability model to maximize mucosal integrity and viability. The model drug lidocaine permeability, 20 kDa fluorescein isothiocyanate-dextran, H&E staining, and mucosal viability were used as evaluation indicators. Firstly, the buccal mucosae of rats, rabbits, dogs, porcine, and humans were analyzed by H&E staining and morphometric analysis to compare the differences. Then, we studied a series of operation methods of isolated mucosa. The buccal mucosae were found to retain their integrity in Kreb's bicarbonate ringer solution at 4 °C for 36 h. Under the long-term storage method with program cooling, freezing at -80 °C, thawing at 37 °C, and using cryoprotectants of 20% glycerol and 20% trehalose, mucosal integrity and biological viability can be maintained for 21 days. The heat separation method was used to prepare a permeability model with a mucosal thickness of 500 μm, which was considered to be the optimal operation. In summary, this study provided an experimental basis for the selection and operation of in vitro penetration models, standardized the research process of isolated mucosa, and improved the accuracy of permeability studies.
© 2022. Controlled Release Society.

Entities:  

Keywords:  Buccal mucosal delivery; Cryoprotectants; Long-term storage; Permeability model

Mesh:

Substances:

Year:  2022        PMID: 35349106     DOI: 10.1007/s13346-022-01151-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   5.671


  41 in total

Review 1.  Modeling the oral cavity: in vitro and in vivo evaluations of buccal drug delivery systems.

Authors:  Viralkumar F Patel; Fang Liu; Marc B Brown
Journal:  J Control Release       Date:  2012-05-22       Impact factor: 9.776

2.  Application of in vitro transmucosal permeability, dose number, and maximum absorbable dose for biopharmaceutics assessment during early drug development for intraoral delivery.

Authors:  Zhen Yang; Sutthilug Sotthivirat; Yunhui Wu; Anita Lalloo; Becky Nissley; Kimberly Manser; Hankun Li
Journal:  Int J Pharm       Date:  2016-02-22       Impact factor: 5.875

3.  A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption.

Authors:  Paola Mura; Serena Orlandini; Marzia Cirri; Francesca Maestrelli; Natascia Mennini; Giada Casella; Sandra Furlanetto
Journal:  Int J Pharm       Date:  2018-06-15       Impact factor: 5.875

4.  Evaluation of different pig oral mucosa sites as permeability barrier models for drug permeation studies.

Authors:  Michelle Franz-Montan; Luciano Serpe; Claudia Cristina Maia Martinelli; Camila Batista da Silva; Cleiton Pita Dos Santos; Pedro Duarte Novaes; Maria Cristina Volpato; Eneida de Paula; Renata Fonseca Vianna Lopez; Francisco Carlos Groppo
Journal:  Eur J Pharm Sci       Date:  2015-10-03       Impact factor: 4.384

Review 5.  In vivo, ex vivo and in vitro assessment of buccal permeation of drugs from delivery systems.

Authors:  Soraia Pinto; Manuela E Pintado; Bruno Sarmento
Journal:  Expert Opin Drug Deliv       Date:  2019-12-03       Impact factor: 6.648

6.  Effect of freezing and type of mucosa on ex vivo drug permeability parameters.

Authors:  Thiago Caon; Cláudia Maria Oliveira Simões
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

7.  Development, validation and standardization of oromucosal ex-vivo permeation studies for implementation in quality-controlled environments.

Authors:  Haidara Majid; Anke Bartel; Bjoern B Burckhardt
Journal:  J Pharm Biomed Anal       Date:  2020-11-20       Impact factor: 3.935

8.  Oromucosal films: from patient centricity to production by printing techniques.

Authors:  Yu Tian; Mine Orlu; Herman J Woerdenbag; Mariagiovanna Scarpa; Olga Kiefer; Dina Kottke; Erica Sjöholm; Heidi Öblom; Niklas Sandler; Wouter L J Hinrichs; Henderik W Frijlink; Jörg Breitkreutz; J Carolina Visser
Journal:  Expert Opin Drug Deliv       Date:  2019-08-08       Impact factor: 6.648

Review 9.  Mucosal drug delivery and 3D printing technologies: A focus on special patient populations.

Authors:  Christina Karavasili; Georgios K Eleftheriadis; Christos Gioumouxouzis; Eleftherios G Andriotis; Dimitrios G Fatouros
Journal:  Adv Drug Deliv Rev       Date:  2021-07-05       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.